Market Overview:
The global chemotherapy drug market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for targeted therapies, and technological advancements in the field of chemotherapy drugs. The global chemotherapy drug market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antimetabolites, plant alkaloids, alkylating agents, and antitumor antibiotics. Antimetabolites are expected to account for the largest share of this market in 2018 owing to their high efficacy and widespread use across different types of cancer. By application, oral chemotherapeutics are expected to dominate this market owing to their ease-of-use and lower cost as compared with intravenous chemotherapeutics.
Product Definition:
A chemotherapy drug is a medication that is used to treat cancer. Chemotherapy drugs work by killing cancer cells or stopping them from growing.
Antimetabolites:
Antimetabolites are chemicals that inhibit the action of methotrexate in the body. They are used as chemotherapy drugs to stop cancerous cells from growing. Antimetabolites can also be used with radiation and surgery to reduce side effects caused by these procedures. Some of the most common types of cancers treated with antimetabolites include breast cancer, lung cancer, colorectal cancer, gastric (stomach)cancer and liver tumors among others.
Plant Alkaloids:
Plant alkaloids are secondary compounds derived from plants. Alkaloids are considered to be toxic substances and have a morphine-like structure. Plant alkaloid can be extracted from different parts of the plant including leaves, bark, roots or even fruits depending upon the type. Some of the common plant alkaloids include caffeine, nicotine, codeine and quinine which are used in various medicines for their pain reducing effect on humans as well as animals.
Application Insights:
The intravenous application segment dominated the global chemotherapy drug market in 2017. This can be attributed to factors such as increasing cancer cases and rising awareness about the availability of advanced treatment options. For instance, according to a study published by NCBI in 2018, around 1.7 million people were diagnosed with cancer and another 2.5 million were estimated to have the disease but not known by a doctor yet across the globe which is expected to increase over the forecast period thus fueling demand for chemotherapy drugs during this time frame.
Oral application is anticipated to witness significant growth over the forecast period owing to increasing consumer awareness regarding early diagnosis.
Regional Analysis:
North America dominated the global chemotherapy drug market in 2017. Key factors contributing to its growth include favorable government initiatives, increasing R&D investments by companies, and rising adoption of modern treatment techniques. For instance, in September 2018, Pfizer Inc. announced that it would invest around USD X billion from 2019 to 2022 on a new research initiative called “ Unleashing Innovation†aimed at developing new therapies for cancer patients.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving economic conditions & healthcare infrastructure coupled with growing patient awareness levels regarding available treatment options & their respective benefits/risks involved.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the chemotherapy drug market. According to a study by the World Health Organization (WHO), an estimated 14 million new cases of cancer were diagnosed in 2012, and this number is expected to increase to 21 million by 2030. This will create a large demand for chemotherapy drugs, which will drive the growth of this market.
- Rising awareness about cancer: There is a growing awareness about different types of cancers and their treatments among people across the world. This has led to an increase in demand for chemotherapy drugs as they are considered one of the most effective treatments for various types of cancers.
- Technological advancements in chemotherapy drugs: The pharmaceutical industry is constantly making advancements in technology that helps improve the efficacy and safety profile of chemotherapy drugs. This will help boost sales growth opportunities for these drugs in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chemotherapy Drug Market Research Report
By Type
Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics
By Application
Oral, Intravenous
By Companies
Pfizer, Eli Lilly, CELGENE, Bristol-Myers Squibb, Merck, GlaxoSmithKline, Novartis, Sanofi, Teva Pharmaceuticals Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Chemotherapy Drug Market Report Segments:
The global Chemotherapy Drug market is segmented on the basis of:
Types
Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral, Intravenous
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Eli Lilly
- CELGENE
- Bristol-Myers Squibb
- Merck
- GlaxoSmithKline
- Novartis
- Sanofi
- Teva Pharmaceuticals Industries
Highlights of The Chemotherapy Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antimetabolites
- Plant Alkaloids
- Alkylating Agents
- Antitumor Antibiotics
- By Application:
- Oral
- Intravenous
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chemotherapy Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chemotherapy drugs are medications used to treat cancer. They work by killing the cancer cells.
Some of the key players operating in the chemotherapy drug market are Pfizer, Eli Lilly, CELGENE, Bristol-Myers Squibb, Merck, GlaxoSmithKline, Novartis, Sanofi, Teva Pharmaceuticals Industries.
The chemotherapy drug market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chemotherapy Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chemotherapy Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chemotherapy Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chemotherapy Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chemotherapy Drug Market Size & Forecast, 2018-2028
4.5.1 Chemotherapy Drug Market Size and Y-o-Y Growth
4.5.2 Chemotherapy Drug Market Absolute $ Opportunity
Chapter 5 Global Chemotherapy Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chemotherapy Drug Market Size Forecast by Type
5.2.1 Antimetabolites
5.2.2 Plant Alkaloids
5.2.3 Alkylating Agents
5.2.4 Antitumor Antibiotics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chemotherapy Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chemotherapy Drug Market Size Forecast by Applications
6.2.1 Oral
6.2.2 Intravenous
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chemotherapy Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chemotherapy Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chemotherapy Drug Analysis and Forecast
9.1 Introduction
9.2 North America Chemotherapy Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chemotherapy Drug Market Size Forecast by Type
9.6.1 Antimetabolites
9.6.2 Plant Alkaloids
9.6.3 Alkylating Agents
9.6.4 Antitumor Antibiotics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chemotherapy Drug Market Size Forecast by Applications
9.10.1 Oral
9.10.2 Intravenous
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chemotherapy Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Chemotherapy Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chemotherapy Drug Market Size Forecast by Type
10.6.1 Antimetabolites
10.6.2 Plant Alkaloids
10.6.3 Alkylating Agents
10.6.4 Antitumor Antibiotics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chemotherapy Drug Market Size Forecast by Applications
10.10.1 Oral
10.10.2 Intravenous
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chemotherapy Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chemotherapy Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chemotherapy Drug Market Size Forecast by Type
11.6.1 Antimetabolites
11.6.2 Plant Alkaloids
11.6.3 Alkylating Agents
11.6.4 Antitumor Antibiotics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chemotherapy Drug Market Size Forecast by Applications
11.10.1 Oral
11.10.2 Intravenous
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chemotherapy Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Chemotherapy Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chemotherapy Drug Market Size Forecast by Type
12.6.1 Antimetabolites
12.6.2 Plant Alkaloids
12.6.3 Alkylating Agents
12.6.4 Antitumor Antibiotics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chemotherapy Drug Market Size Forecast by Applications
12.10.1 Oral
12.10.2 Intravenous
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chemotherapy Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chemotherapy Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chemotherapy Drug Market Size Forecast by Type
13.6.1 Antimetabolites
13.6.2 Plant Alkaloids
13.6.3 Alkylating Agents
13.6.4 Antitumor Antibiotics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chemotherapy Drug Market Size Forecast by Applications
13.10.1 Oral
13.10.2 Intravenous
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chemotherapy Drug Market: Competitive Dashboard
14.2 Global Chemotherapy Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Eli Lilly
14.3.3 CELGENE
14.3.4 Bristol-Myers Squibb
14.3.5 Merck
14.3.6 GlaxoSmithKline
14.3.7 Novartis
14.3.8 Sanofi
14.3.9 Teva Pharmaceuticals Industries
